Touqui L, Chignard M, Jacquemin C, Wal F, Vargaftig B B
Experientia. 1984 Apr 15;40(4):374-7. doi: 10.1007/BF01952560.
Platelet-activating-factor (PAF-acether, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is formed by and released from rabbit platelets stimulated with thrombin, with the ionophore A23187, with collagen and with the platelet-stimulating glycoprotein convulxin. We here show that 3-deazaadenosine (C3ado) and L-homocysteine (HCy), two inhibitors of platelet methylation, reduced the formation of PAF-acether and of its deacetylated product lyso-PAF-acether by rabbit platelets challenged with thrombin, under conditions where the accompanying aggregation was not significantly modified. In contrast, platelet aggregation induced by convulxin was completely and irreversibly blocked when C3ado and HCy were associated. Aggregation by thrombin was not affected by the methylation inhibitors even when ADP was scavenged and thromboxane formation was suppressed. Our results indicate that phospholipid methylation, thrombin-induced platelet aggregation and formation of PAF-acether can be dissociated. The formation of PAF-acether by rabbit platelets can be blocked by mechanisms other than inhibition of phospholipase A2, since the latter is not affected by C3ado and/or HCy.
血小板活化因子(PAF-乙醚,1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱)由凝血酶、离子载体A23187、胶原蛋白和血小板刺激糖蛋白convulxin刺激的兔血小板生成并释放。我们在此表明,两种血小板甲基化抑制剂3-脱氮腺苷(C3ado)和L-同型半胱氨酸(HCy),在伴随的聚集未被显著改变的条件下,减少了受凝血酶刺激的兔血小板中PAF-乙醚及其脱乙酰化产物溶血PAF-乙醚的形成。相比之下,当C3ado和HCy联合使用时,convulxin诱导的血小板聚集被完全且不可逆地阻断。即使清除了ADP并抑制了血栓素的形成,凝血酶诱导的聚集也不受甲基化抑制剂的影响。我们的结果表明,磷脂甲基化、凝血酶诱导的血小板聚集和PAF-乙醚的形成可以被分离。兔血小板中PAF-乙醚的形成可以通过抑制磷脂酶A2以外的机制被阻断,因为后者不受C3ado和/或HCy的影响。